ArticleOncotarget2015

Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets.

Leonardo Mirandola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.